Cytek Biosciences, Inc. - Common Stock (CTKB)

185 filings reported holding CTKB - Cytek Biosciences, Inc. - Common Stock as of Q2 2025.
Cytek Biosciences, Inc. - Common Stock (CTKB) has 156 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 79.4M shares of 127M outstanding shares and own 62.71% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (17M shares), VANGUARD GROUP INC (7.77M shares), BROWN CAPITAL MANAGEMENT LLC (7.11M shares), HHLR ADVISORS, LTD. (6.66M shares), Topline Capital Management, LLC (5.23M shares), STATE STREET CORP (4.17M shares), DIMENSIONAL FUND ADVISORS LP (3.45M shares), GEODE CAPITAL MANAGEMENT, LLC (2.73M shares), NEW YORK STATE COMMON RETIREMENT FUND (2.09M shares), and ROYCE & ASSOCIATES LP (1.39M shares).
This table shows the top 156 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.